Lung mucin production is stimulated by the air pollutant residual oil fly ash

M Longphre1, D Li, J Li

  • 1Department of Anatomy and Cardiovascular Research Institute, University of California, San Francisco 94143, USA.

Insights

Particulate air pollution, like residual oil fly ash (ROFA), increases mucus and lysozyme production in airway cells. Vanadium in ROFA drives this response, potentially by affecting cell signaling pathways.

Area of Science:

  • Environmental Health
  • Cell Biology
  • Toxicology

Background:

  • Particulate air pollution is linked to respiratory issues like excess mucus and infection susceptibility.
  • Residual oil fly ash (ROFA) is a significant air pollutant with unknown effects on respiratory defenses.

Purpose of the Study:

  • To investigate how ROFA affects the production of mucin (MUC5AC) and lysozyme (LYS) in epithelial cells.
  • To identify the specific components and signaling pathways involved in ROFA-induced responses.

Main Methods:

  • In vitro exposure of epithelial cells to ROFA.
  • Measurement of MUC5AC and LYS mRNA levels.
  • Reporter assays to assess transcriptional regulation.
  • Testing individual ROFA components, particularly vanadium.
  • Screening of signaling inhibitors.

Main Results:

  • ROFA exposure increased MUC5AC and LYS mRNA steady state levels in epithelial cells.
  • Upregulation was partly controlled at the transcriptional level.
  • Vanadium was identified as the primary component responsible for the observed effects.
  • Distinct, yet phosphotyrosine-dependent, signaling pathways mediated MUC5AC and LYS induction.

Conclusions:

  • Vanadium-containing air pollutants, like ROFA, may induce disease-like conditions by interfering with normal cellular defense mechanisms.
  • The findings suggest a mechanism where pollutants unmask pathogen resistance pathways through tyrosine phosphatase inhibition.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...